Clinical Trial

Exogenous Ketone Esters for Refractory Status Epileptics

Study acronym: EKERSE
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated November 27, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to investigate the efficacy of add-on exogenous ketone esters for the treatment of children with refractory generalized convulsive status epilepticus
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-12-31; most recent amendment 2024-11-26.
Status change: Not Yet Recruiting → Recruiting 2023-01-18
Trial Details
NCT Number NCT05674552
Lead Sponsor Sohag University
Conditions Status Epilepticus
Enrollment 50 participants
Start Date 2023-01-10
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-27